Multi-Modality Therapy for Cancer of the Esophagus and GE Junction

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer

(2012) P Kelly et al.   BRITISH JOURNAL OF CANCER

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma

(2011) J. A. Chan et al.   ANNALS OF ONCOLOGY

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

(2011) Harry H Yoon et al.   BMC CANCER

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

(2011) H. H. Yoon et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer

(2011) R. Wong et al.   CLINICAL ONCOLOGY

The Impact of Time Elapsed Between Endoscopic Ultrasound and Esophagectomy on Concordance of Ultrasonographic and Pathologic Staging of Esophageal Malignancy

(2011) Jessica M. Fisher et al.   DIGESTIVE DISEASES AND SCIENCES

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma

(2011) Lawrence P. Leichman et al.   JOURNAL OF CLINICAL ONCOLOGY

18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial

(2011) C. Meyer zum Buschenfelde et al.   JOURNAL OF NUCLEAR MEDICINE

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Original article: Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability

(2010) L. M. A. Schreurs et al.   DISEASES OF THE ESOPHAGUS

Induction Chemoradiotherapy Increases Pleural and Pericardial Complications after Esophagectomy for Cancer

(2010) Sudish C. Murthy et al.   Journal of Thoracic Oncology

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma

(2009) H-L. Zhang et al.   DISEASES OF THE ESOPHAGUS

Epidemiology of Esophageal Cancer

(2009) Guy D. Eslick   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer

(2009) William H. Allum et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

(2009) Michael Stahl et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

(2009) Robert A. Meguid et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction

(2009) David J. Adelstein et al.   Journal of Thoracic Oncology

Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer

(2009) Jeongmin Choi et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy

(2008) Christian G. Peyre et al.   ANNALS OF SURGERY

Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity

(2008) Howard Safran et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY